These meta-analysis results indicated that UGT1A1 rs3755319, UGT2B7 rs7662029, and rs7439366 might be associated with the risk of AT-DILI, which would help to identify susceptible populations for liver injury in patients with anti-TB treatment. Here, UGT2B7 is linked to tuberculosis.